Data / Form D filings / XYLOS Corp
XYLOS Corp: Form D filings
XYLOS Corp, a biotechnology company in Langhorne, PA, filed 3 Form D notices with the SEC between 2010 and 2011. The latest, on August 5, 2011, reports $400,000 sold of a $2 million offering to 13 investors.
Find out what XYLOS Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 838 TOWN CENTER DRIVE, Langhorne, PA, 19047
- Phone
- (215) 867-0220
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1232545
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2011 | New notice | $1,980,000 | $400,000 | $1,580,000 | 13 | Jul 25, 2011 | sec.gov |
| Mar 16, 2011 | New notice | $2,000,000 | $750,000 | $1,250,000 | 16 | Mar 2, 2011 | sec.gov |
| May 19, 2010 | New notice | $2,500,000 | $1,500,000 | $1,000,000 | 30 | May 4, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric T. Converse | Director | |
| Mark S. McNulty | Executive Officer, Director | |
| Gregory M. Zaic | Director | |
| Constance L. Ace | Executive Officer | |
| Gonzalo C. Serafica | Executive Officer | |
| Paul J. Gordon | Director | |
| Seth S. Pierrepont | Director | |
| David S. Rovee | Director | |
| John M. Pietruski | Director | |
| Frits M. Vromen | Director | |
| Richard S. Mink | Executive Officer |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Aug 1, 2011 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what XYLOS Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.